Janux 治疗公司
US ˙ NasdaqGM ˙ US47103J1051

介绍

本页面提供了有关 Jay Lichter 已知的内部交易历史的全面分析。内部人士包括公司的高管、董事或重要投资者。一般而言，基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是，他们必须通过Form 4向美国证券交易委员会（SEC）报告所有交易。尽管存在这些限制，学术研究表明，整体而言，内部人士在自己公司中的投资表现往往优于市场。

平均交易盈利能力

“平均交易盈利能力”衡量了内部人士在过去三年中所有非计划性的公开市场买入交易的平均回报率。计算过程包括检查每笔交易，排除了作为10b5-1交易计划的一部分的交易。然后，对每笔交易在3、6和12个月的表现进行平均，以生成该笔交易最终的表现指标。然后，将所有交易的表现指标进行平均，计算出内部人士的总体平均表现指标。列表仅包含在过去两年中进行过至少三笔交易的内部人士。

如果内部人士的交易盈利能力显示为"N/A"，则可能是因为该内部人士在过去三年内没有进行任何公开市场买入交易，或者他们进行的交易距离现在时间太近，无法计算出可靠的表现指标。

更新频率：每日

查看收益最高的的内幕交易者列表。

查看排名最高的内部人士。
报告内部持仓的公司

美国证券交易委员会（SEC）文件显示Jay Lichter已报告在以下公司拥有持仓或进行了交易：

证券 职位 最新报告的持仓
US:JANX / Janux Therapeutics, Inc. 10% Owner 7,000
US:OTIC / Otonomy Inc Director 17,500
US:THOR / Synthorx Inc Director 0
US:PETX / Aratana Therapeutics, Inc. Director 2,345,543
如何解读这些图表

以下图表显示了在Jay Lichter进行的每笔公开市场非计划交易后证券的股价表现。非计划交易是指没有作为10b5-1交易计划的一部分而进行的交易。股价表现以累积百分比变化的方式绘制。例如，如果一笔内部人士交易是在2019年1月1日进行的，该图表将显示该证券的每日百分比变化直至当前日期。如果在此期间股价从10美元涨至15美元，则股价的累积百分比变化将为50%。从10美元涨至20美元的价格变化将为100%，而从10美元跌至5美元的价格变化将为-50%。

最终，我们将评估内部人士的交易与股价的超额回报（正向或负向）之间的相关性，以判断内部人士是否在交易中利用内部信息获利。如果内部人士有这样的行为，我们预期看到（a）买入后的正回报，或者（b）卖出后的负回报。对于情况（a），买入图表将显示一系列向上倾斜的曲线，表示每次买入后都有正回报。对于情况（b），卖出图表将显示一系列向下倾斜的曲线，表示每次卖出后都有负回报。

然而，仅凭这一点还不足以得出结论。例如，如果公司的股价在多年内呈现非周期性上升，我们会预期所有买入后的图表都呈现向上倾斜。同样地，多年来呈现非周期性下降的股价会导致卖出后的图表也呈现向下倾斜。这两种情况的图表都不能表示内部人士在进行内幕交易。

最有力的指标是在公司股价呈极度循环波动的情况下，“买入”图表显示正向信号，而“卖出”图表显示负向趋势。这种情况强烈暗示内部人士可能根据内幕信息精确地计时进行交易，以获得财务优势。

JANX / Janux Therapeutics, Inc.内部人士买入 - 短期收益分析

在这一部分，我们分析了在 JANX / Janux Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最高利润的
天数		 达到最高利润时的
价格		 最高
利润($)		 最高回报率（%）
2023-11-13 JANX Lichter Jay 849,854 5.8700 849,854 5.8700 4,988,643 172 64.7800 50,064,900 1,003.58
2021-06-15 JANX Lichter Jay 629,411 17.0000 629,411 17.0000 10,699,987

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

JANX / Janux Therapeutics, Inc. Insider Trades
JANX / Janux Therapeutics, Inc.内部人士卖出 - 短期亏损分析

在这一部分，我们分析了在 JANX / Janux Therapeutics, Inc. 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期 股票代码 内部人士 报告
股数		 报告
价格		 经调整
股数		 经调整
价格		 成本基础 达到最低利润的
天数		 达到最低利润时的
价格		 避免的
最高损失金额($)		 避免的
最高损失率($)
2024-10-18 JANX Avalon Ventures XI, L.P. 102,732 50.3000 102,732 50.3000 5,167,420 293 22.5800 -2,847,730 -55.11
2024-10-18 JANX Avalon Ventures XI, L.P. 19,900 50.3000 19,900 50.3000 1,000,970
2024-10-18 JANX Avalon Ventures XI, L.P. 104,892 50.3000 104,892 50.3000 5,276,068
2024-10-18 JANX Avalon Ventures XI, L.P. 15,462 51.1800 15,462 51.1800 791,345
2024-10-18 JANX Avalon Ventures XI, L.P. 2,995 51.1800 2,995 51.1800 153,284
2024-10-18 JANX Avalon Ventures XI, L.P. 15,788 51.1800 15,788 51.1800 808,030
2024-10-18 JANX Avalon Ventures XI, L.P. 541,824 44.7500 541,824 44.7500 24,246,624
2024-10-18 JANX Avalon Ventures XI, L.P. 104,957 44.7500 104,957 44.7500 4,696,826
2024-10-18 JANX Avalon Ventures XI, L.P. 553,219 44.7500 553,219 44.7500 24,756,550
2024-10-17 JANX Avalon Ventures XI, L.P. 1,843 50.0200 1,843 50.0200 92,187
2024-10-16 JANX Avalon Ventures XI, L.P. 60,179 49.6900 60,179 49.6900 2,990,295
2024-10-16 JANX Avalon Ventures XI, L.P. 11,657 49.6900 11,657 49.6900 579,236
2024-10-16 JANX Avalon Ventures XI, L.P. 61,445 49.6900 61,445 49.6900 3,053,202
2024-10-16 JANX Avalon Ventures XI, L.P. 29,474 50.6100 29,474 50.6100 1,491,679
2024-10-16 JANX Avalon Ventures XI, L.P. 5,710 50.6100 5,710 50.6100 288,983
2024-10-16 JANX Avalon Ventures XI, L.P. 30,094 50.6100 30,094 50.6100 1,523,057
2024-10-16 JANX Avalon Ventures XI, L.P. 10,957 50.8000 10,957 50.8000 556,616
2024-09-30 JANX Avalon Ventures XI, L.P. 958 46.2400 958 46.2400 44,298
2024-09-27 JANX Avalon Ventures XI, L.P. 45,894 46.4200 45,894 46.4200 2,130,399
2024-09-27 JANX Avalon Ventures XI, L.P. 8,894 46.4200 8,894 46.4200 412,859
2024-09-27 JANX Avalon Ventures XI, L.P. 46,861 46.4200 46,861 46.4200 2,175,288
2024-09-27 JANX Avalon Ventures XI, L.P. 1,511 47.7400 1,511 47.7400 72,135
2024-09-27 JANX Avalon Ventures XI, L.P. 293 47.7400 293 47.7400 13,988
2024-09-27 JANX Avalon Ventures XI, L.P. 1,542 47.7400 1,542 47.7400 73,615
2024-09-27 JANX Avalon Ventures XI, L.P. 1,826 46.1900 1,826 46.1900 84,343
2024-09-26 JANX Avalon Ventures XI, L.P. 49,497 46.7800 49,497 46.7800 2,315,470
2024-09-26 JANX Avalon Ventures XI, L.P. 9,592 46.7800 9,592 46.7800 448,714
2024-09-26 JANX Avalon Ventures XI, L.P. 50,539 46.7800 50,539 46.7800 2,364,214
2024-09-26 JANX Avalon Ventures XI, L.P. 40,803 47.7700 40,803 47.7700 1,949,159
2024-09-26 JANX Avalon Ventures XI, L.P. 7,908 47.7700 7,908 47.7700 377,765
2024-09-26 JANX Avalon Ventures XI, L.P. 41,661 47.7700 41,661 47.7700 1,990,146
2024-09-13 JANX Lichter Jay 3,815 46.6800 3,815 46.6800 178,084
2024-09-12 JANX Avalon Ventures XI, L.P. 158,031 47.0000 158,031 47.0000 7,427,457
2024-09-12 JANX Avalon Ventures XI, L.P. 30,613 47.0000 30,613 47.0000 1,438,811
2024-09-12 JANX Avalon Ventures XI, L.P. 161,356 47.0000 161,356 47.0000 7,583,732
2024-09-10 JANX Avalon Ventures XI, L.P. 11,319 46.1300 11,319 46.1300 522,145
2024-09-10 JANX Avalon Ventures XI, L.P. 2,193 46.1300 2,193 46.1300 101,163
2024-09-10 JANX Avalon Ventures XI, L.P. 11,557 46.1300 11,557 46.1300 533,124
2024-09-10 JANX Avalon Ventures XI, L.P. 34,326 46.6600 34,326 46.6600 1,601,651
2024-09-10 JANX Avalon Ventures XI, L.P. 6,649 46.6600 6,649 46.6600 310,242
2024-09-10 JANX Avalon Ventures XI, L.P. 35,047 46.6600 35,047 46.6600 1,635,293
2024-09-09 JANX Avalon Ventures XI, L.P. 2,182 42.3300 2,182 42.3300 92,364
2024-09-06 JANX Avalon Ventures XI, L.P. 108,365 42.0000 108,365 42.0000 4,551,330
2024-09-06 JANX Avalon Ventures XI, L.P. 20,991 42.0000 20,991 42.0000 881,622
2024-09-06 JANX Avalon Ventures XI, L.P. 110,644 42.0000 110,644 42.0000 4,647,048
2024-06-03 JANX Lichter Jay 677,279 54.7500 677,279 54.7500 37,081,025
2024-06-03 JANX Lichter Jay 131,196 54.7500 131,196 54.7500 7,182,981
2024-06-03 JANX Lichter Jay 691,525 54.7500 691,525 54.7500 37,860,994

经调整价格 已按拆股调整。经调整股数 已按拆股调整。

JANX / Janux Therapeutics, Inc. Insider Trades
内幕交易历史

该表格显示了由 Jay Lichter 进行的所有内幕交易的完整列表，这些交易已向美国证券交易委员会（SEC）披露。

备案日期 交易日期 表格 股票代码 证券 代码 10b5-1 股数 剩余股数 %
变化		 每股
股价		 交易
金额		 剩余
金额
2024-10-24 2024-09-13 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -3,815 7,000 -35.28 46.68 -178,084 326,760
2024-10-24 2024-09-13 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 391 10,815 3.75 39.80 15,562 430,437
2024-10-24 2024-09-13 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 778 10,424 8.07 13.22 10,285 137,805
2024-10-24 2024-09-13 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 778 9,646 8.77 10.73 8,348 103,502
2024-10-24 2024-09-13 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 1,868 8,868 26.69 17.00 31,756 150,756
2024-10-18 2024-10-18 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -553,219 2,115,373 -20.73 44.75 -24,756,550 94,662,942
2024-10-18 2024-10-18 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -104,957 401,321 -20.73 44.75 -4,696,826 17,959,115
2024-10-18 2024-10-18 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -541,824 2,071,799 -20.73 44.75 -24,246,624 92,713,005
2024-10-18 2024-10-18 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -15,788 2,668,592 -0.59 51.18 -808,030 136,578,539
2024-10-18 2024-10-18 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -2,995 506,278 -0.59 51.18 -153,284 25,911,308
2024-10-18 2024-10-18 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -15,462 2,613,623 -0.59 51.18 -791,345 133,765,225
2024-10-18 2024-10-18 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -104,892 2,684,380 -3.76 50.30 -5,276,068 135,024,314
2024-10-18 2024-10-18 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -19,900 509,273 -3.76 50.30 -1,000,970 25,616,432
2024-10-18 2024-10-18 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -102,732 2,629,085 -3.76 50.30 -5,167,420 132,242,976
2024-10-18 2024-10-17 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -1,843 6,371 -22.44 50.02 -92,187 318,677
2024-10-18 2024-10-17 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 237 8,214 2.97 39.80 9,433 326,917
2024-10-18 2024-10-17 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 348 7,977 4.56 13.22 4,601 105,456
2024-10-18 2024-10-17 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 348 7,629 4.78 10.73 3,734 81,859
2024-10-18 2024-10-17 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 836 7,281 12.97 17.00 14,212 123,777
2024-10-18 2024-10-16 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -10,957 6,445 -62.96 50.80 -556,616 327,406
2024-10-18 2024-10-16 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 1,407 17,402 8.80 39.80 55,999 692,600
2024-10-18 2024-10-16 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 2,070 15,995 14.87 13.22 27,365 211,454
2024-10-18 2024-10-16 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 2,070 13,925 17.46 10.73 22,211 149,415
2024-10-18 2024-10-16 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 4,968 11,855 72.14 17.00 84,456 201,535
2024-10-18 2024-10-16 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -30,094 2,789,272 -1.07 50.61 -1,523,057 141,165,056
2024-10-18 2024-10-16 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -5,710 529,173 -1.07 50.61 -288,983 26,781,446
2024-10-18 2024-10-16 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -29,474 2,731,817 -1.07 50.61 -1,491,679 138,257,258
2024-10-18 2024-10-16 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -61,445 2,819,366 -2.13 49.69 -3,053,202 140,094,297
2024-10-18 2024-10-16 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -11,657 534,883 -2.13 49.69 -579,236 26,578,336
2024-10-18 2024-10-16 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -60,179 2,761,291 -2.13 49.69 -2,990,295 137,208,550
2024-09-30 2024-09-30 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -958 6,887 -12.21 46.24 -44,298 318,455
2024-09-30 2024-09-30 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 123 7,845 1.59 39.80 4,895 312,231
2024-09-30 2024-09-30 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 181 7,722 2.40 13.22 2,393 102,085
2024-09-30 2024-09-30 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 181 7,541 2.46 10.73 1,942 80,915
2024-09-30 2024-09-30 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 434 7,360 6.27 17.00 7,378 125,120
2024-09-30 2024-09-27 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -1,826 6,926 -20.86 46.19 -84,343 319,912
2024-09-30 2024-09-27 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 234 8,752 2.75 39.80 9,313 348,330
2024-09-30 2024-09-27 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 345 8,518 4.22 13.22 4,561 112,608
2024-09-30 2024-09-27 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 345 8,173 4.41 10.73 3,702 87,696
2024-09-30 2024-09-27 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 828 7,828 11.83 17.00 14,076 133,076
2024-09-30 2024-09-27 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -1,542 2,880,811 -0.05 47.74 -73,615 137,529,917
2024-09-30 2024-09-27 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -293 546,540 -0.05 47.74 -13,988 26,091,820
2024-09-30 2024-09-27 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -1,511 2,821,470 -0.05 47.74 -72,135 134,696,978
2024-09-30 2024-09-27 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -46,861 2,882,353 -1.60 46.42 -2,175,288 133,798,826
2024-09-30 2024-09-27 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -8,894 546,833 -1.60 46.42 -412,859 25,383,988
2024-09-30 2024-09-27 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -45,894 2,822,981 -1.60 46.42 -2,130,399 131,042,778
2024-09-30 2024-09-26 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -41,661 2,929,214 -1.40 47.77 -1,990,146 139,928,553
2024-09-30 2024-09-26 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -7,908 555,727 -1.40 47.77 -377,765 26,547,079
2024-09-30 2024-09-26 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -40,803 2,868,875 -1.40 47.77 -1,949,159 137,046,159
2024-09-30 2024-09-26 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -50,539 2,970,875 -1.67 46.78 -2,364,214 138,977,532
2024-09-30 2024-09-26 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -9,592 563,635 -1.67 46.78 -448,714 26,366,845
2024-09-30 2024-09-26 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -49,497 2,909,678 -1.67 46.78 -2,315,470 136,114,737
2024-09-12 2024-09-12 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -161,356 3,021,414 -5.07 47.00 -7,583,732 142,006,458
2024-09-12 2024-09-12 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -30,613 573,227 -5.07 47.00 -1,438,811 26,941,669
2024-09-12 2024-09-12 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -158,031 2,959,175 -5.07 47.00 -7,427,457 139,081,225
2024-09-12 2024-09-10 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -35,047 3,182,770 -1.09 46.66 -1,635,293 148,508,048
2024-09-12 2024-09-10 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -6,649 603,840 -1.09 46.66 -310,242 28,175,174
2024-09-12 2024-09-10 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -34,326 3,117,206 -1.09 46.66 -1,601,651 145,448,832
2024-09-12 2024-09-10 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -11,557 3,217,817 -0.36 46.13 -533,124 148,437,898
2024-09-12 2024-09-10 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -2,193 610,489 -0.36 46.13 -101,163 28,161,858
2024-09-12 2024-09-10 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -11,319 3,151,532 -0.36 46.13 -522,145 145,380,171
2024-09-10 2024-09-09 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -2,182 7,000 -23.76 42.33 -92,364 296,310
2024-09-10 2024-09-09 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 277 9,182 3.11 39.80 11,025 365,444
2024-09-10 2024-09-09 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 414 8,905 4.88 13.22 5,473 117,724
2024-09-10 2024-09-09 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 414 8,491 5.13 10.73 4,442 91,108
2024-09-10 2024-09-09 4 JANX Janux Therapeutics, Inc.
Common Stock 		M - Exercise 994 8,077 14.03 17.00 16,898 137,309
2024-09-10 2024-09-06 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -110,644 3,229,374 -3.31 42.00 -4,647,048 135,633,708
2024-09-10 2024-09-06 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -20,991 612,682 -3.31 42.00 -881,622 25,732,644
2024-09-10 2024-09-06 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -108,365 3,162,851 -3.31 42.00 -4,551,330 132,839,742
2024-06-28 2024-06-26 4 JANX Janux Therapeutics, Inc.
Common Stock 		A - Award 2,500 7,083 54.55
2024-06-05 2024-06-03 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -691,525 3,340,018 -17.15 54.75 -37,860,994 182,865,986
2024-06-05 2024-06-03 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -131,196 633,673 -17.15 54.75 -7,182,981 34,693,597
2024-06-05 2024-06-03 4 JANX Janux Therapeutics, Inc.
Common Stock 		S - Sale -677,279 3,271,216 -17.15 54.75 -37,081,025 179,099,076
2023-11-15 2023-11-13 4 JANX Janux Therapeutics, Inc.
Common Stock 		P - Purchase 849,854 849,854 5.87 4,988,643 4,988,643
2021-06-24 2021-06-22 4 OTIC OTONOMY, INC.
Stock Option (right to buy) 		A - Award 17,500 17,500
2021-06-16 2021-06-15 4 JANX Janux Therapeutics, Inc.
Series B Convertible Preferred Stock 		C - Conversion -900,264 0 -100.00
2021-06-16 2021-06-15 4 JANX Janux Therapeutics, Inc.
Series A Convertible Preferred Stock 		C - Conversion -2,105,264 0 -100.00
2021-06-16 2021-06-15 4 JANX Janux Therapeutics, Inc.
Series A Convertible Preferred Stock 		C - Conversion -526,316 0 -100.00
2021-06-16 2021-06-15 4 JANX Janux Therapeutics, Inc.
Series Seed 2 Convertible Preferred Stock 		C - Conversion -1,859,634 0 -100.00
2021-06-16 2021-06-15 4 JANX Janux Therapeutics, Inc.
Series Seed Convertible Preferred Stock 		C - Conversion -888,888 0 -100.00
2021-06-16 2021-06-15 4 JANX Janux Therapeutics, Inc.
Common Stock 		P - Purchase 629,411 4,479,492 16.35 17.00 10,699,987 76,151,364
2021-06-16 2021-06-15 4 JANX Janux Therapeutics, Inc.
Common Stock 		C - Conversion 1,153,238 3,850,081 42.76
2021-06-16 2021-06-15 4 JANX Janux Therapeutics, Inc.
Common Stock 		C - Conversion 2,696,843 2,696,843
2021-06-16 2021-06-15 4 JANX Janux Therapeutics, Inc.
Common Stock 		C - Conversion 674,211 4,387,217 18.16
2021-06-16 2021-06-15 4 JANX Janux Therapeutics, Inc.
Common Stock 		C - Conversion 2,382,191 3,713,006 179.00
2021-06-16 2021-06-15 4 JANX Janux Therapeutics, Inc.
Common Stock 		C - Conversion 1,138,665 1,330,815 592.59
2021-06-14 2021-06-10 4 JANX Janux Therapeutics, Inc.
Stock Option (right to buy) 		A - Award 30,000 30,000
2021-06-10 3 JANX Janux Therapeutics, Inc.
Common Stock 		192,150
2021-03-03 2021-03-03 4 OTIC OTONOMY, INC.
Common Stock 		S - Sale -113,935 0 -100.00 2.70 -307,397
2021-03-03 2021-03-03 4 OTIC OTONOMY, INC.
Common Stock 		S - Sale -207,245 0 -100.00 2.70 -559,147
2021-03-02 2021-03-02 4 OTIC OTONOMY, INC.
Common Stock 		S - Sale -138,199 113,935 -54.81 2.90 -400,639 330,298
2021-03-02 2021-03-02 4 OTIC OTONOMY, INC.
Common Stock 		S - Sale -251,375 207,245 -54.81 2.90 -728,736 600,803
2021-03-02 2021-03-01 4 OTIC OTONOMY, INC.
Common Stock 		S - Sale -61,619 252,134 -19.64 2.86 -175,984 720,095
2021-03-02 2021-03-01 4 OTIC OTONOMY, INC.
Common Stock 		S - Sale -112,081 458,620 -19.64 2.86 -320,103 1,309,819
2021-03-02 2021-02-26 4 OTIC OTONOMY, INC.
Common Stock 		S - Sale -117,262 313,753 -27.21 2.83 -331,851 887,921
2021-03-02 2021-02-26 4 OTIC OTONOMY, INC.
Common Stock 		S - Sale -213,292 570,701 -27.21 2.83 -603,616 1,615,084
2021-02-25 2021-02-25 4 OTIC OTONOMY, INC.
Common Stock 		S - Sale -110,361 431,015 -20.39 2.95 -326,006 1,273,218
2021-02-25 2021-02-25 4 OTIC OTONOMY, INC.
Common Stock 		S - Sale -200,739 783,993 -20.39 2.95 -592,983 2,315,915
2021-02-25 2021-02-24 4 OTIC OTONOMY, INC.
Common Stock 		S - Sale -178,484 541,376 -24.79 2.98 -532,239 1,614,383
2021-02-25 2021-02-24 4 OTIC OTONOMY, INC.
Common Stock 		S - Sale -324,651 984,732 -24.79 2.98 -968,109 2,936,471
2021-02-25 2021-02-23 4 OTIC OTONOMY, INC.
Common Stock 		S - Sale -95,113 719,860 -11.67 2.89 -274,686 2,078,956
2021-02-25 2021-02-23 4 OTIC OTONOMY, INC.
Common Stock 		S - Sale -173,005 1,309,383 -11.67 2.89 -499,638 3,781,498
2020-06-25 2020-06-23 4 OTIC OTONOMY, INC.
Stock Option (right to buy) 		A - Award 17,500 17,500
2020-01-24 2020-01-23 4 THOR Synthorx, Inc.
Stock Option (right to buy) 		D - Sale to Issuer -15,335 0 -100.00 55.60 -852,626
2020-01-24 2020-01-23 4 THOR Synthorx, Inc.
Stock Option (right to buy) 		D - Sale to Issuer -30,000 0 -100.00 57.00 -1,710,000
2020-01-24 2020-01-23 4 THOR Synthorx, Inc.
Common Stock 		U - Other -1,682,086 0 -100.00 68.00 -114,381,848
2020-01-24 2020-01-23 4 THOR Synthorx, Inc.
Common Stock 		U - Other -448,567 0 -100.00 68.00 -30,502,556
2020-01-24 2020-01-23 4 THOR Synthorx, Inc.
Common Stock 		U - Other -150,000 0 -100.00 68.00 -10,200,000
2020-01-16 2020-01-14 4 THOR Synthorx, Inc.
Common Stock 		J - Other 448,567 448,567
2020-01-16 2020-01-14 4 THOR Synthorx, Inc.
Common Stock 		J - Other -4,598,796 150,000 -96.84
2019-06-13 2019-06-11 4 OTIC OTONOMY, INC.
Stock Option (right to buy) 		A - Award 17,500 17,500
2019-06-10 2019-06-07 4 THOR Synthorx, Inc.
Stock Option (right to buy) 		A - Award 15,335 15,335
2018-12-13 2018-12-11 4 THOR Synthorx, Inc.
Series C Preferred Stock 		C - Conversion -1,821,156 0 -100.00
2018-12-13 2018-12-11 4 THOR Synthorx, Inc.
Series C Preferred Stock 		C - Conversion -4,033,283 0 -100.00
2018-12-13 2018-12-11 4 THOR Synthorx, Inc.
Series B Preferred Stock 		C - Conversion -1,221,896 0 -100.00
2018-12-13 2018-12-11 4 THOR Synthorx, Inc.
Series A Preferred Stock 		C - Conversion -2,053,534 0 -100.00
2018-12-13 2018-12-11 4 THOR Synthorx, Inc.
Common Stock 		P - Purchase 545,455 1,682,086 47.99 11.00 6,000,005 18,502,946
2018-12-13 2018-12-11 4 THOR Synthorx, Inc.
Common Stock 		C - Conversion 1,136,631 1,136,631
2018-12-13 2018-12-11 4 THOR Synthorx, Inc.
Common Stock 		C - Conversion 2,517,278 4,748,796 112.81
2018-12-13 2018-12-11 4 THOR Synthorx, Inc.
Common Stock 		C - Conversion 762,617 2,231,518 51.92
2018-12-13 2018-12-11 4 THOR Synthorx, Inc.
Common Stock 		C - Conversion 1,281,664 1,468,901 684.51
2018-12-07 2018-12-06 4 THOR Synthorx, Inc.
Stock Option (right to buy) 		A - Award 30,000 30,000
2018-12-06 3 THOR Synthorx, Inc.
Common Stock 		374,474
2018-12-06 3 THOR Synthorx, Inc.
Common Stock 		374,474
2018-12-06 3 THOR Synthorx, Inc.
Common Stock 		374,474
2018-06-20 2018-06-19 4 OTIC OTONOMY, INC.
Stock Option (right to buy) 		A - Award 17,500 17,500
2017-09-05 2017-08-31 4 OTIC OTONOMY, INC.
Warrant to Purchase Common Stock (Right to Buy) 		M - Exercise -14,106 0 -100.00
2017-09-05 2017-08-31 4 OTIC OTONOMY, INC.
Warrant to Purchase Common Stock (Right to Buy) 		M - Exercise -14,106 0 -100.00
2017-09-05 2017-08-31 4 OTIC OTONOMY, INC.
Warrant to Purchase Common Stock (Right to Buy) 		M - Exercise -14,106 0 -100.00
2017-09-05 2017-08-31 4 OTIC OTONOMY, INC.
Warrant to Purchase Common Stock (Right to Buy) 		M - Exercise -14,106 0 -100.00
2017-09-05 2017-08-31 4 OTIC OTONOMY, INC.
Warrant to Purchase Common Stock (Right to Buy) 		M - Exercise -14,106 0 -100.00
2017-09-05 2017-08-31 4 OTIC OTONOMY, INC.
Warrant to Purchase Common Stock (Right to Buy) 		M - Exercise -14,106 0 -100.00
2017-09-05 2017-08-31 4 OTIC OTONOMY, INC.
Warrant to Purchase Common Stock (Right to Buy) 		M - Exercise -14,106 0 -100.00
2017-09-05 2017-08-31 4 OTIC OTONOMY, INC.
Warrant to Purchase Common Stock (Right to Buy) 		M - Exercise -14,106 0 -100.00
2017-09-05 2017-08-31 4 OTIC OTONOMY, INC.
Warrant to Purchase Common Stock (Right to Buy) 		M - Exercise -14,106 0 -100.00
2017-09-05 2017-08-31 4 OTIC OTONOMY, INC.
Warrant to Purchase Common Stock (Right to Buy) 		M - Exercise -14,106 0 -100.00
2017-09-05 2017-08-31 4 OTIC OTONOMY, INC.
Common Stock 		F - Taxes -108,851 2,297,361 -4.52 18.37 -1,999,593 42,202,522
2017-09-05 2017-08-31 4 OTIC OTONOMY, INC.
Common Stock 		M - Exercise 141,060 2,406,212 6.23 14.18 2,000,231 34,120,086
2017-07-14 2017-06-20 4 OTIC OTONOMY, INC.
Stock Option (right to buy) 		A - Award 15,000 15,000
2016-06-21 2016-06-21 4 OTIC Otonomy, Inc.
Stock Option (right to buy) 		A - Award 15,000 15,000
2015-07-17 2015-07-15 4 PETX ARATANA THERAPEUTICS, INC.
COMMON STOCK 		J - Other -1,000,000 2,345,543 -29.89
2015-06-22 2015-06-19 4 OTIC Otonomy, Inc.
06/19/2015 		A - Award 15,000 15,000
2015-06-19 2015-06-18 4 PETX ARATANA THERAPEUTICS, INC.
Stock Option (Right to Buy) 		A - Award 10,000 10,000
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock Warrant (right to buy) 		X - Other -91,011 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock Warrant (right to buy) 		C - Conversion 91,011 91,011
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Series C Preferred Stock Warrant (right to buy) 		C - Conversion -91,011 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock Warrant (right to buy) 		C - Conversion 14,106 14,106
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock Warrant (right to buy) 		C - Conversion 14,106 14,106
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Series A Preferred Stock Warrant (right to buy) 		C - Conversion -6,432 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Series A Preferred Stock Warrant (right to buy) 		C - Conversion -6,432 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock Warrant (right to buy) 		C - Conversion 14,106 14,106
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Series A Preferred Stock Warrant (right to buy) 		C - Conversion -6,432 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock Warrant (right to buy) 		C - Conversion 14,106 14,106
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Series A Preferred Stock Warrant (right to buy) 		C - Conversion -6,432 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock Warrant (right to buy) 		C - Conversion 14,106 14,106
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Series A Preferred Stock Warrant (right to buy) 		C - Conversion -6,432 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock Warrant (right to buy) 		C - Conversion 14,106 14,106
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Series A Preferred Stock Warrant (right to buy) 		C - Conversion -6,432 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock Warrant (right to buy) 		C - Conversion 14,106 14,106
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Series A Preferred Stock Warrant (right to buy) 		C - Conversion -6,432 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock Warrant (right to buy) 		C - Conversion 14,106 14,106
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Series A Preferred Stock Warrant (right to buy) 		C - Conversion -6,432 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock Warrant (right to buy) 		C - Conversion 14,106 14,106
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Series A Preferred Stock Warrant (right to buy) 		C - Conversion -6,432 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock Warrant (right to buy) 		C - Conversion 14,106 14,106
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Series A Preferred Stock Warrant (right to buy) 		C - Conversion -6,432 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Series D Preferred Stock 		C - Conversion -136,770 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Series C Preferred Stock 		C - Conversion -568,828 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Series C Preferred Stock 		C - Conversion -484,691 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Series B Preferred Stock 		C - Conversion -175,889 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Series A Preferred Stock 		C - Conversion -337,432 0 -100.00
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock 		P - Purchase 109,375 814,973 15.50 16.00 1,750,000 13,039,568
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock 		C - Conversion 705,598 705,598
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock 		S - Sale -50,001 1,450,179 -3.33 16.00 -800,016 23,202,864
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock 		X - Other 91,011 1,500,180 6.46 8.79 799,987 13,186,582
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock 		C - Conversion 660,580 1,409,169 88.24
2014-08-19 2014-08-18 4 OTIC Otonomy, Inc.
Common Stock 		C - Conversion 740,057 748,589 8,673.90
2014-08-12 3 OTIC Otonomy, Inc.
Common Stock 		17,064
2014-08-12 3 OTIC Otonomy, Inc.
Common Stock 		17,064
2014-06-23 2014-06-19 4 PETX ARATANA THERAPEUTICS, INC.
Stock Option (Right to Buy) 		A - Award 10,000 10,000
2014-02-05 2014-02-03 4 PETX ARATANA THERAPEUTICS, INC.
Common Stock 		S - Sale -825,000 3,345,543 -19.78 19.00 -15,675,000 63,565,317
2014-02-04 2013-07-02 4/A PETX ARATANA THERAPEUTICS, INC.
COMMON STOCK 		P - Purchase 500,000 4,170,543 13.62 6.00 3,000,000 25,023,258
2013-07-03 2013-07-02 4 PETX ARATANA THERAPEUTICS, INC.
SERIES C CONVERTIBLE PREFERRED STOCK 		C - Conversion -375,000 0 -100.00
2013-07-03 2013-07-02 4 PETX ARATANA THERAPEUTICS, INC.
SERIES B CONVERTIBLE PREFERRED STOCK 		C - Conversion -1,333,333 0 -100.00
2013-07-03 2013-07-02 4 PETX ARATANA THERAPEUTICS, INC.
SERIES A CONVERTIBLE PREFERRED STOCK 		C - Conversion -4,000,000 0 -100.00
2013-07-03 2013-07-02 4 PETX ARATANA THERAPEUTICS, INC.
COMMON STOCK 		C - Conversion 3,434,616 3,670,545 1,455.78
2013-06-28 2013-06-26 4 PETX ARATANA THERAPEUTICS, INC.
STOCK OPTION (RIGHT TO BUY) 		A - Award 21,058 21,058
2013-06-26 3 PETX ARATANA THERAPEUTICS, INC.
COMMON STOCK 		9,025
P
非衍生或衍生证券的公开市场或私下买入
S
非衍生或衍生证券的公开市场或私下卖出
A
公司向内部人员授予、奖励或以其他方式获取证券（例如股票期权）
C
衍生工具转换
D
将证券卖出或转让回公司
F
使用从公司收到的证券的一部分来支付行使价或税务负担。
G
内部人士赠送或接收他人赠送公司股票
K
股权掉期和类似的避险交易
M
行使或转换从公司获得的衍生证券（例如期权）
V
内部人士通过Form 4自愿报告的一笔交易
J
其他（附有交易描述的脚注）